XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.24.3

MERGER WITH CIBUS GLOBAL | 9 Months Ended
--- | ---
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] |
MERGER WITH CIBUS GLOBAL | MERGER WITH CIBUS GLOBALAs described in Note 1, on May 31, 2023, the Company completed the Merger Transactions. Redeemable Noncontrolling Interest All of the issued and outstanding Cibus Global membership units (Common Units) are held solely by the Company and certain members of Cibus Global who elected in connection with the Merger Transactions to receive units (Up-C Units), each consisting of one share of Class B Common Stock and one Common Unit, at the closing of the Merger Transactions (Electing Members). The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. In accordance with ASC 810, Consolidation, Cibus Global is considered a Variable Interest Entity with Cibus as its sole managing member and primary beneficiary. As such, Cibus consolidates Cibus Global, and the remaining Common Unit holders that hold economic interest directly in Cibus Global are presented as redeemable noncontrolling interest on the Company’s financial statements. There are no restrictions on the use of assets of Cibus Global. Redeemable noncontrolling interest represents the portion of Cibus Global Common Units that are not owned directly by the Company. Redeemable noncontrolling interest is classified as temporary equity because the Common Units contained certain redemption features that were not solely within the control of the Company. As of May 31, 2023, (the closing date of the Merger Transactions) the Common Unit holders of the redeemable noncontrolling interest owned approximately 22 percent of Cibus Global. As of September 30, 2024, the Common Unit holders of the redeemable noncontrolling interest owned approximately 11 percent of Cibus Global. Purchase Price The purchase price for Cibus Global was determined as follows:
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1) |  | 20,150,838 |
Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2) |  | $ | 31.50 |
Purchase price |  | $ | 634,751,397 |
___________________________________________ (1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which are treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. (2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions. Purchase Price Allocation The acquisition of Cibus Global was accounted for using the acquisition method, whereby all of the assets acquired and liabilities assumed were recognized at their fair value on the acquisition date, with any excess of the purchase price over the estimated fair value recorded as goodwill. Identifiable assets acquired, liabilities assumed, and noncontrolling interest, if applicable, are recorded at their estimated fair values at the acquisition date. Significant judgment is required in determining the acquisition date fair value of the assets acquired and liabilities assumed, predominantly with respect to intangible assets and the Royalty Liability. Evaluations included numerous inputs, including forecasted cash flows that incorporate the specific attributes of each asset. The Company evaluated all available information, as well as all appropriate methodologies, when determining the fair value of assets acquired, liabilities assumed, and noncontrolling interest. In addition, the Company determined the amortization period and method of amortization for each finite-lived intangible asset. The following table sets forth the allocation of the consideration:
In Thousands |  | May 31, 2023
Cash and cash equivalents |  | $ | 59,381 |
Accounts receivable |  | 2,216 |
Due from related parties |  | 19 |
Note receivable |  | 2,500 |
Prepaid expenses and other current assets |  | 2,535 |
Property, plant and equipment |  | 10,588 |
Operating lease right-of-use-assets |  | 9,519 |
Goodwill |  | 585,266 |
Intangible assets |  | 135,429 |
Other non-current assets |  | 457 |
Accounts payable |  | (5,582) |
Accrued expenses |  | (3,477) |
Accrued compensation |  | (2,859) |
Due to related parties |  | (8) |
Deferred revenue |  | (1,186) |
Current portion of notes payable |  | (517) |
Current portion of operating lease obligations |  | (4,687) |
Current portion of financing lease obligations |  | (165) |
Other current liabilities |  | (17) |
Notes payable, net of current portion |  | (749) |
Operating lease obligations, net of current portion |  | (6,006) |
Financing lease obligations, net of current portion |  | (10) |
Royalty liability - related parties |  | (146,360) |
Other non-current liabilities |  | (1,536) |
Consideration transferred |  | $ | 634,751 |
Receivables have been recognized at their fair value, and the Company has not recognized, and it does not expect, any credit losses and therefore expects cash flows to match the recognized receivables. Intangible Assets Acquired Intangible assets acquired, and their related average useful lives, were as follows:
In Thousands, except useful life |  | May 31, 2023 |  | Weighted Average Amortization (Years)
In-process research and development |  | $ | 99,051 |  |  | Indefinite
Developed technology |  | 14,148 |  |  | 20
Trade name |  | 22,230 |  |  | 20
Total |  | $ | 135,429 |  |  |
The weighted average amortization period for the Company's finite-lived intangible assets, including developed technology and trade names, was 20 years. The Company incurred expenses of approximately $8.2 million in connection with the completion of the Merger Transactions, of which approximately $0.4 million was recognized in 2022. During 2023, approximately $3.5 million in legal and professional fees, $1.9 million in severance costs resulting from pre-existing employment agreements, and $1.1 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, were included in SG&A expense in the condensed consolidated statements of operations. Additionally, during 2023, approximately $1.3 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, was included in R&D expense in the condensed consolidated statements of operations. These unaudited pro forma figures for the three and nine months ended September 30, 2023, have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. The unaudited pro forma financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.
|  |  |  | Three Months Ended |  |  |  | Nine Months Ended
Unaudited and in Thousands |  |  |  | September 30, 2023 |  |  |  | September 30, 2023
Pro forma revenues |  |  |  | $ | 475 |  |  |  |  | $ | 1,154 |
Pro forma net loss |  |  |  | (34,528) |  |  |  |  | (88,474) |
Pro forma net loss attributable to controlling interest |  |  |  | (24,575) |  |  |  |  | (70,855) |
Pro forma net loss attributable to redeemable noncontrolling interest |  |  |  | $ | (9,953) |  |  |  |  | $ | (17,619) |
Tax Receivable Agreement In conjunction with the Merger Transactions, the Company entered into a Tax Receivable Agreement (TRA) with the Electing Members. Pursuant to the TRA, the Company generally will be required to pay to the Electing Members, in the aggregate, 85 percent of the net income tax savings that the Company actually realizes (or in certain circumstances, is deemed to realize) as a result of (i) certain favorable tax attributes the Company acquired from the blocker entities party to the Merger Agreement in connection with the Merger Transactions (including net operating losses), (ii) increases to the Company's allocatable share of the tax basis of Cibus Global's assets resulting from future redemptions or exchanges of Common Units for shares of Class A Common Stock or cash, (iii) tax attributes resulting from certain payments made under the TRA and (iv) deductions in respect of interest under the TRA. The payment obligations under the TRA are the Company's obligations and not obligations of Cibus Global. During the nine months ended September 30, 2024, there were 30,120 Up-C Units exchanged by Electing Members for shares of Class A Common Stock. As of September 30, 2024, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more likely than not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability has been recorded as of September 30, 2024.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/805/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205-20/tableOfContent + Details
Name: | us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration